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Abstract: Inbred GN hamsters were infected intratesticularly with infective larvae of Bru-
gia pahangi. The new route of infection produced localized infection of filariae in the
testis and its peritesticular tissues. Using this model, developing 3rd- and 4th-stage
larvae in hamsters were treated with diethylcarbamazine. The results showed that the
recovery rate of worms in the non-treated control group was 80%, while those of the
treated groups were 14.2 and 26.9%.
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The intratesticular inoculation of infective larvae of Brugia pahangi into inbred GN
hamsters (Mesocricetus auratus) was reported to be a useful technique which could pro-
duce localized infection in the inoculated testis and resulted in very high recovery rate
of developing larvae (Kimura et al., 1984a). In the testis, the 3rd molt occurred at 7-8
days postinoculation, and the 4th molt was seen after 24 days. In the present study, this
newroute of infection was used in studying the effect of diethylcarbamazine citrate (DEC)
on the 3rd- and 4th-stage larvae of B. pahangi.
Infective larvae of B. pahangi were obtained from Aedes aegypti fed on a micro-
filariae positive Mongolian jird (Meriones unguiculatus) ll days previously. They were
washed five times in sterilized Hanks' balanced salt solution (HBSS). Twenty GN ham-
sters of 3-5 months old were infected by inoculating 28~30 infective larvae in about 0.05
ml of HBSS into the left testis of each animal using a 22-gauge needle. The hamsters
were then divided into the following four groups of five hamsters each. Group I was
treated intraperitoneally with DEC (SupatoninÖ, Tanabe Seiyaku Co. , Ltd.) at 300 mg/
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kg/day at days 1, 2, 3, 4 and 5 postinoculation, and necropsied one animal per day at
days 6, 7, 8, 9 and 10. Group II was treated at the same dosage at days ll, 12, 13,
14 and 15, and necropsied one animal per day at days 16, 17, 18, 19 and 20. Group
III and Group IV were control groups matching respectively with Group I and Group II.
They were treated intraperitoneally with 0.7 ml of normal saline, with which DEC solution
was diluted to the required concentration. The autopsy was carried out following Kimura
et al. (1984b) and the number of larvae were recorded by site of recovery.
In control groups, the average recovery rate of larvae was 79.3%. Most of the
recovered larvae (88.9% in Group III, 54.7% in Group IV) were obtained from the
inoculated testis,.which was followed by the peritesticular tissues of the inoculated side
(5.1% in Group III, 33.3% in Group IV). The "peritesticular tissues" include epididy-
mis, ductus deferens and adipose tissue attaching to the testis. In DEC -treated groups,
the average recovery rates for Group I and Group II were 14.2% and 26.9% respectively.
Again the majority of recovery (81.0% in Group I, 74.4% in Group II) was obtained
from the inoculated testis. The peritesticular tissues of the inoculated side accounted for
14.3% and 20.5% respectively in Group I and Group II (Table 1).
These results indicate that DEC is effective against 3rd- and 4th-stage larvae of B.
pahangi in GN hamsters. There was no significant difference of recovery between the
T able 1. Distribution and recovery rate of B. pahangi inoculated intratesticularly into
GN hamsters and treated with DEC against 3rd- and 4th-stage larvae
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treated control
(Group I) (Group III)
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treated control
(Group II) (Group IV)








































recovered'krVae 21 (10(» H7 C100) 39(100) 117(100)
% Recovery 14.2 79.1 26.9 79.6
( ) : Percentage to the total number of larvae recovered.
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two stages of development statistically. The reason why DEC could not eliminate all the
larvae was not known, but the low plasma concentration of DEC in rodents (Kimura et
al. , 1984c) may have relevance to this.
When we use subcutaneously-infected rodent models for experimental chemotherapy
of filariasis, the recovery rates of worms from control animals are not satisfactorily high.
For example, Shigeno et al. (1983) reported that, when developing larvae of B. pahangi
in subcutaneously-infected Mongolian jirds were treated with DEC at 300mg/kg/day for
5 consecutive days, the recovery rates for 3rd- and 4th- stage larvae were 9.1% and
4.9% respectively, compared with 43.1% in the non-treated control. The results have
raised a question on what would happen to more than 50% of the inoculated larvae which
could not be recovered in the control group. Our new model showed high recovery rate
(about 80%) in control groups, and thus provided more confirmative evidence of the ef-
fect of DEC against 3rd- and 4th- stage larvae. In addition, by using the present ani-
mal model, 88-95% of the recovered worms were obtained from the inoculated testis and
the peritesticular tissues of the inoculated side. Thus the examination of only these two
sites, which can be easily excised en bloc, will probably be sufficient in future chemo-
therapeutic studies.
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近交系ハムスダーの睾丸内接種モデルを用いたBrugia pahangi3期・4期幼虫に対するジエチ
ルカルバマジンの治療効果
木村英作,青木克己,重野鎮義,坂本信(長崎大学熱帯医学研究所寄生虫学部門%
近交系ハムスターの睾丸内に,Brugia pahangi感染幼虫を接種すると,睾丸とその周囲に限局
するフィラリア感染を起すことができる.このモデルを用いB. pahangi3期・4期幼虫に対
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するジエチルカルバマジンの治療実験を行なった.その結果,非治療対照群では接種数の約80%
の虫体が回収されたのに対し,治療群では14-27%であった.回収虫体のほとんどは接種睾丸と
その周囲組織より得られるので,今後の治療実験ではこの部分の検査のみで十分である.この新
しいモデルにより,治療実験における虫体回収率は従来の約2倍となり,かつ回収作業が著しく
容易になった.
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